Go Deep
CorMedix Inc.
CorMedix Inc. Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 22,518 | 3.6 | 1.25 | 0.32 | 703.78 |
| Oct 2026 | 22,518 | 3.6 | 1.25 | 0.32 | 701.66 |
| Oct 2026 | 22,485 | 3.6 | 1.26 | 0.32 | 708.41 |
| Oct 2026 | 22,579 | 3.5 | 1.23 | 0.32 | 687.63 |
| Oct 2026 | 22,323 | 3.6 | 1.25 | 0.32 | 699.74 |
| Oct 2026 | 22,233 | 3.7 | 1.28 | 0.32 | 717.76 |
| Oct 2026 | 22,130 | 3.8 | 1.32 | 0.32 | 736.80 |
| Oct 2026 | 21,985 | 4.0 | 1.37 | 0.32 | 764.57 |
| Oct 2026 | 22,102 | 3.7 | 1.33 | 0.32 | 744.04 |
CorMedix Inc. Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | 99,307,000.0 | 127,427,000.0 | 128,615,264.0 | 104,275,289.0 |
| Net Profit | 25,988,000.0 | 38,601,000.0 | 14,020,141.0 | 108,562,980.0 |
| EPS | 0.3 | 0.5 | 0.2 | 1.4 |
CorMedix Inc. Revenue & Profit: Last 4 Years
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Revenue | 311,709,000.0 | 43,472,000.0 | 0.0 | 65,408.0 |
| Net Profit | 163,055,000.0 | -17,930,000.0 | -46,339,227.0 | -29,701,705.0 |
| EPS | 2.2 | -0.3 | -0.9 | -0.7 |
CorMedix Inc. Balance Sheet
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Total Assets | 826,142,000.0 | 118,846,000.0 | 82,059,957.0 | 62,038,259.0 | — |
| Total Liabilities | 420,835,000.0 | 34,189,000.0 | 11,917,528.0 | 6,978,523.0 | — |
| Total Equity | 405,307,000.0 | 84,657,000.0 | 70,142,429.0 | 55,059,736.0 | — |
Owes vs Owns
CorMedix Inc. owed $0.49 for every $1 it owned in Jun 2026, up from $0.11 in Dec 2022.
| Period | Jun 2026 | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|---|
| Owes vs Owns | 0.49× | 0.51× | 0.29× | 0.15× | 0.11× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
CorMedix Inc. Assets & Liabilities Breakdown (USD millions)
What it owns — Dec 2025
Cash & short-term investments 18.0%Receivables 20.7%Inventory 3.6%Fixed assets (tangible) 1.1%Intangible assets 49.5%Long-term investments 1.3%Other assets 5.8%
How it's funded — Dec 2025
Long-term debt 17.5%Payables 1.0%Other liabilities 32.3%Shareholders' equity 49.1%
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 148.5 | 51.7 | 76.0 | 58.8 |
| Receivables | 171.2 | 51.7 | 0.0 | 0.0 |
| Inventory | 29.7 | 7.6 | 2.1 | 0.0 |
| Fixed assets (tangible) | 9.0 | 2.3 | 2.5 | 2.4 |
| Intangible assets | 409.1 | 1.8 | 0.0 | 0.0 |
| Long-term investments | 10.4 | 0.0 | 0.0 | 0.0 |
| Other assets | 48.2 | 3.7 | 1.4 | 0.9 |
| Liabilities & equity | ||||
| Short-term debt | 1.4 | 0.2 | 0.2 | 0.1 |
| Long-term debt | 144.6 | 0.3 | 0.5 | 0.7 |
| Payables | 7.9 | 1.7 | 4.3 | 2.2 |
| Other liabilities | 266.9 | 32.0 | 7.0 | 4.0 |
| Shareholders' equity | 405.3 | 84.7 | 70.1 | 55.1 |
| Net tangible assets | -3.8 | 82.8 | 70.1 | 55.1 |
CorMedix Inc. Cash Flow
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Operating Activities | 175,046,000.0 | -50,615,000.0 | -38,409,480.0 | -24,356,732.0 | — |
| Investing Activities | -308,430,000.0 | 21,231,000.0 | -17,061,685.0 | -3,709,364.0 | — |
| Financing Activities | 238,453,000.0 | 26,319,000.0 | 55,916,804.0 | 17,898,241.0 | — |